MiMARK Diagnostics
PrivateLast Round
Seed
Nov 27, 2023
Total Funding Raised
$6.44M
Company Overview
MiMARK Diagnostics operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Seed round in November 2023.
MiMARK Diagnostics is a biotechnology company developing in-vitro diagnostic solutions for gynecological diseases, with an initial focus on a test for endometrial cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MiMARK Diagnostics Comparables
Compare MiMARK Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PinkDx | 85% | |
| AOA Dx | 78% | |
| Guzip Biomarkers Corporation | 76% |
For institutional investors. Book with your work email.
MiMARK Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 27, 2023 | ||||
| Grant | Feb 11, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MiMARK Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Seed |
| CDTI Innvierte | Seed |
| Inveready | Seed |
| EIT Health | Grant |
| Nara Capital | Seed |
| Namarel Ventures | Seed |
| Clave Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 16, 2026
Grew 27% QoQ, from 22 to 28 employees.
- Feb 20, 2024
Grew 50% QoQ, from 12 to 18 employees.
For institutional investors. Book with your work email.
MiMARK Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MiMARK Diagnostics's valuation, stock price, and market status.
Is MiMARK Diagnostics a public or private company?
MiMARK Diagnostics is a private company.
What is the current stock price of MiMARK Diagnostics?
MiMARK Diagnostics is a private company, so its shares have no public market price. Caplight tracks MiMARK Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MiMARK Diagnostics worth (valuation)?
Valuation information for MiMARK Diagnostics is not publicly available.
Can I buy MiMARK Diagnostics stock?
MiMARK Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MiMARK Diagnostics's last funding round?
MiMARK Diagnostics's most recent funding round was Seed on November 27, 2023.
Who are the main investors in MiMARK Diagnostics?
Key investors in MiMARK Diagnostics include European Innovation Council Fund, CDTI Innvierte, Inveready, EIT Health, Nara Capital.
Will MiMARK Diagnostics IPO soon?
No public IPO plans have been announced for MiMARK Diagnostics.
How can I track MiMARK Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in MiMARK Diagnostics's shares on secondary markets.